DuPont Leader Updates 2013 Agriculture Research Pipeline with Investors

   DuPont Leader Updates 2013 Agriculture Research Pipeline with Investors

Agriculture & Nutrition Segments Spur Growth, Product Development Across Food
Value Chain

PR Newswire

NEW YORK, Feb. 26, 2013

NEW YORK, Feb. 26, 2013 /PRNewswire/ -- At the Goldman Sachs 17^th Annual
Agribusiness Conference today, DuPont Executive Vice President James C. Borel
highlighted 2013 growth drivers and advancements of its agriculture research
pipeline to sustain innovation across its seed, crop protection and nutrition
and health businesses. Recent portfolio changes continue to solidify DuPont's
unique ability to address the global food security challenge by providing
solutions across the food value chain.

"Ongoing global dynamics like increased urbanization in developing economies
and consumer demand for protein-rich diets continue to strain today's
agriculture and food system. Farmers, grocers and food manufacturers seek new
innovations to produce and package safe, nutritious food," said Borel.
"DuPont is uniquely positioned to leverage science to provide options and
local solutions that help feed a growing global population."

DuPont's recent acquisition of Danisco and full ownership of Solae further
strengthen the company's ability to bring new innovation and solutions to
customers across the food value chain.

Borel discussed the 2013 agriculture research pipeline that features an
integrated approach to product development including germplasm, native and
biotech traits, with 12 product advancements including 4program additions as
a result of sustained R&D efforts.

Following the strong commercial launches of Optimum® AQUAmax™ hybrids,
Optimum® AcreMax® insect protection and Optimum® AcreMax® Xtra products in
2012, this year's pipeline advancements underscore DuPont Pioneer's progress
in bringing local solutions to growers' biggest challenges. Together with the
solid growth of DuPont Crop Protection's DuPont™ Rynaxypyr®, and launches of
DuPont™ Cyazypyr™, Dermacor® seed treatment and Penthiopyrad, DuPont's
Agriculture pipeline is delivering today and poised for future growth.

"Our ability to unlock our strong seed germplasm potential using
biotechnology, sustainable chemistry profiles and leading nutrition science
demonstrates DuPont science at work for the global marketplace. Our unique
routes-to-market, application development capabilities and local footprint
ensures a close relationship with growers and food companies alike to bring
tangible solutions from the ground up," Borel said.

Borel used the Brazil corn business as an example of successful product
introductions combined with our advantaged route-to-market. Using advanced
breeding and biotechnology, DuPont scientists have created unique products
like Optimum® Intrasect®, with two modes of action for lepidopteran insect
control, and early soybean varieties and corn hybrids uniquely designed to
enable safrinha double-cropping systems. These high-yielding products with
native and biotech protection, delivered through our system of local sales
professionals helped DuPont Pioneer achieve a multi-point gain in corn market
share in the Brazil summer season and position us for continued growth in the
current safrinha season.

To view a full copy of today's presentation, visit the "Events &
Presentations" page on the DuPont Investor Center.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the
global marketplace in the form of innovative products, materials, and services
since 1802. The company believes that by collaborating with customers,
governments, NGOs, and thought leaders we can help find solutions to such
global challenges as providing enough healthy food for people everywhere,
decreasing dependence on fossil fuels, and protecting life and the
environment. For additional information about DuPont and its commitment to
inclusive innovation, please visit

Forward-Looking Statements: This news release contains forward-looking
statements based on management's current expectations, estimates and
projections. The company does not undertake to update any forward-looking
statements as a result of future developments or new information. All
statements that address expectations or projections about the future,
including statements about the company's strategy for growth, product
development, market position, expected expenditures and financial results are
forward-looking statements. Some of the forward-looking statements may be
identified by words like "expects," "anticipates," "plans," "intends,"
"projects," "indicates," and similar expressions. These statements are not
guarantees of future performance and involve a number of risks, uncertainties
and assumptions. Many factors, including those discussed more fully elsewhere
in this release and in DuPont's filings with the Securities and Exchange
Commission, particularly its latest annual report on Form 10-K, as well as
others, could cause results to differ materially from those stated. These
factors include, but are not limited to changes in the laws, regulations,
policies and economic conditions of countries in which the company does
business; competitive pressures; successful integration of structural changes,
including acquisitions, divestitures and alliances; research and development
of new products, including regulatory approval and market acceptance, and
seasonality of sales of agricultural products.

The DuPont Oval Logo, DuPont™, Optimum®, AQUAmax™, AcreMax®, Intrasect®,
Rynaxypyr®, Cyazypyr™ and Dermacor® are trademarks or registered trademarks of
DuPont or its affiliates.


Contact: Jennifer Goldston, +1-515-535-5774,
Press spacebar to pause and continue. Press esc to stop.